Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberté versus TAXUS express stents.

@article{Turco2012EconomicMO,
  title={Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Libert{\'e} versus TAXUS express stents.},
  author={Mark A. Turco and Anuraag R. Kansal and Sean Stern and Stacey L. Amorosi and Paul L Underwood and Greg D E Lissovoy and Keith D. Dawkins},
  journal={Journal of interventional cardiology},
  year={2012},
  volume={25 4},
  pages={
          353-63
        }
}
BACKGROUND With the changing health care environment, cost effectiveness is an important adjunct to clinical investigation when assessing new medical devices. This study presents an economic model to evaluate cost effectiveness of coronary stents. METHODS Markov modeling was developed comparing total costs (Medicare payer perspective) between TAXUS Liberté and TAXUS Express based on 3-year clinical outcomes from the TAXUS ATLAS Small Vessel and Long Lesion trials. RESULTS The TAXUS Libert… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 11 REFERENCES

A Comprehensive Guidebook to the DRG Classification System

  • DRG Expert
  • Ingenix, Eden Prairie, MN,
  • 2010

for Windows

  • BOO RED
  • Ann Arbor, MI: Thomson Reuters Healthcare,
  • 2010

Similar Papers

Loading similar papers…